Core Viewpoint - Titan Technology and its affiliate, Shanghai Titan HeYuan Phase I Private Investment Fund, plan to jointly invest in Titan MicroSource Testing Technology Co., Ltd, increasing its registered capital from 10 million to 50 million yuan, with Titan holding 70% and the fund holding 30% after the investment [2][4]. Group 1: Investment Overview - The investment aims to enhance the overall development strategy and business needs of the company [4]. - The registered capital of MicroSource Testing will increase by 40 million yuan, with Titan contributing 25 million yuan and the fund contributing 15 million yuan [2][4]. - The funding for Titan's investment will come from its own funds [2]. Group 2: Transaction Details - The investment constitutes a related party transaction but does not qualify as a major asset restructuring under relevant regulations [3][8]. - The transaction has been approved by the company's board and does not require shareholder approval [3][8][20]. - In the past 12 months, related party transactions have not exceeded 1% of the company's audited total assets or market value, and have not surpassed 30 million yuan [3][9]. Group 3: Target Company Information - MicroSource Testing was established in February 2025 and focuses on laboratory services, including verification and testing services, equipment leasing, and key component R&D [12]. - The company has not yet commenced operations and will rely on Titan for initial support, including technical management and resources [12]. - As the business expands, MicroSource Testing will develop its own operational and technical teams [12]. Group 4: Investment Rationale and Impact - The joint investment is intended to improve the company's business layout and integrate resources for enhanced competitive advantage [18]. - The investment will not affect the company's normal operations or independence, as both parties are using their own funds [18]. - The transaction is based on voluntary, fair, and reasonable principles, ensuring no harm to the interests of the company or its shareholders [18][20].

Core Viewpoint - Titan Technology (688133.SH) plans to increase capital in MicroSource Detection, reflecting the company's overall development strategy and business needs [1] Group 1: Investment Details - The registered capital of MicroSource Detection before the capital increase was 10 million yuan, fully owned by Titan Technology [1] - After the capital increase, the registered capital will rise to 50 million yuan, with Titan Technology holding 70% and the first-phase fund holding 30% [1] - The additional 40 million yuan in registered capital will be contributed by Titan Technology (25 million yuan) and the first-phase fund (15 million yuan), with Titan Technology using its own funds for this investment [1] Group 2: Company Overview - MicroSource Detection was established in February 2025 and focuses on three core areas: validation and testing services, rental and after-sales of analytical testing instruments, and R&D of key components for analytical testing equipment [1] - The company aims to become a leading independent biochemical laboratory one-stop service platform in China [1] - Currently, MicroSource Detection has not commenced operations and will rely on Titan Technology for initial support, including technical management, industry resources, and some facilities and equipment [1] Group 3: Future Development - As MicroSource Detection expands its business, it plans to establish an independent operational team, technical team, and ERP system, functioning as a wholly-owned subsidiary of Titan Technology [1]